Search Within

Ellin Berman

Formats
  1. Journal Article (95)
  2. Meeting Abstract (68)
  3. Conference Paper (6)
  4. Guidelines (2)
  5. Review (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Adult Leukemia (176)
  2. Center for Hematologic Malignancies (176)
  3. Department of Medicine (176)
  4. Hematologic Malignancies, Division of (176)
  5. Sloan Kettering Institute Faculty (44)
  6. Molecular Pharmacology and Chemistry Program Faculty (41)

More Groups

People
  1. Bayard Clarkson (29)
  2. Timothy Gee (26)
  3. Martin Tallman (17)
  4. Peter Maslak (17)
  5. Sanford Kempin (17)
  6. David Scheinberg (15)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (7)

More Years

Publications
  1. Blood (54)
  2. Journal of Clinical Oncology (20)
  3. Journal of the National Comprehensive Cancer Network (12)
  4. Leukemia (11)
  5. Leukemia Research (6)
  6. Bone Marrow Transplantation (5)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (20)
  3. Nature Publishing Group (17)
  4. Harborside Press (12)
  5. Elsevier Inc. (9)
  6. American Association for Cancer Research (8)

More Publishers

Results (176)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN Guidelines
    Journal Article

    Pallera, A.; Altman, J. K.; Berman, E.; Abboud, C. N.; Bhatnagar, B.; Curtin, P.; DeAngelo, D. J.; Gotlib, J.; Tanner Hagelstrom, R.; Hobbs, G.; more...
    Journal of the National Comprehensive Cancer Network (2016)

    Fulltext@MSK | Save
  • Genetic basis of the effects of bone on hematopoietic aging and disease
    Meeting Abstract

    Kousteni, S.; Nakagawa, M.; Berman, E.
    Experimental Hematology (2016)

    Fulltext@MSK | Save
  • Very young patients with chronic lymphocytic leukemia have lower incidence of adverse cytogenetics and improved overall survival: 10-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Devlin, S.; Park, J.; Tallman, M.; Berman, E.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation
    Journal Article

    Berman, E.; Maloy, M.; Devlin, S.; Jhanwar, S.; Papadopoulos, E.; Jakubowski, A.
    Leukemia Research (2016)

    Fulltext@MSK | Save
  • FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice
    Journal Article

    Kode, A.; Mosialou, I.; Manavalan, S. J.; Rathinam, C. V.; Friedman, R. A.; Teruya-Feldstein, J.; Bhagat, G.; Berman, E.; Kousteni, S.
    Leukemia (2016)

    Fulltext@MSK | Save
  • Targeting the osteoblast in myelodysplasia and acute myeloid leukemia
    Meeting Abstract

    Nakagawa, M. M.; Kode, A.; Manavalan, S. J.; Bhagat, G.; Teruya-Feldstein, J.; Raza, A.; Berman, E.; Kousteni, S.
    Blood (2015)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • Foxo1 expressed in osteoblasts promotes the leukemogenic properties of β-catenin by activating Notch signaling
    Meeting Abstract

    Kode, A.; Mosialou, I.; Manavalan, S. J.; Feldstein, J. T.; Bhagat, G.; Berman, E.; Kousteni, S.
    Blood (2014)

    Fulltext@MSK | Save
  • Where exactly does ponatinib fit in chronic myelogenous leukemia?
    Journal Article

    Berman, E.
    Journal of the National Comprehensive Cancer Network (2014)

    Fulltext@MSK | Save